These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26087105)

  • 61. A Case of Intertriginous and Flexural Exanthema caused by Amoxicillin.
    Cancela-Díez B; López-Delgado D; Aneiros-Fernandez J; Ruiz-Villaverde R
    Sultan Qaboos Univ Med J; 2019 Nov; 19(4):e369-e371. PubMed ID: 31897322
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Symmetrical drug-related intertriginous and flexural exanthema-like eruption: An addition to the spectrum of coronavirus disease 2019-related cutaneous findings.
    Çakıcı ÖA; Güder S; Salman A; Ergun T
    Indian J Dermatol Venereol Leprol; 2022; 88(6):814-816. PubMed ID: 36332096
    [No Abstract]   [Full Text] [Related]  

  • 63. Docetaxel-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing.
    Hampel A; Kinaciyan T
    Contact Dermatitis; 2024 May; 90(5):525-527. PubMed ID: 38263696
    [No Abstract]   [Full Text] [Related]  

  • 64. Symmetrical drug-related intertriginous and flexural exanthema with high-risk systemic features: a unique clinical phenotype in hospitalized patients.
    Kirven RM; Fisher K; Kaffenberger BH; Chung CG; Korman AM
    Arch Dermatol Res; 2024 May; 316(6):279. PubMed ID: 38796524
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Three cases of symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by proton-pump inhibitors.
    Spigariolo CB; Barei F; Maronese CA; Barberi F; Cattaneo A; Violetti SA
    Australas J Dermatol; 2022 Nov; 63(4):509-512. PubMed ID: 35877187
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Maculopapular eruption caused by doripenem.
    Shibata M; Sawada Y; Yamaguchi T; Ohmori S; Haruyama S; Yoshioka M; Okada E; Nakamura M
    Eur J Dermatol; 2017 Apr; 27(2):197-198. PubMed ID: 28007670
    [No Abstract]   [Full Text] [Related]  

  • 67. First Case of Symmetric Drug-Related Intertriginous and Flexural Exanthema Induced by Meropenem.
    Blanco Garcia-Granero D; Barranco R; García-Moguel I; Velasco V; Diéguez Pastor MC
    J Investig Allergol Clin Immunol; 2021 Dec; 31(6):516-517. PubMed ID: 33661103
    [No Abstract]   [Full Text] [Related]  

  • 68. Symmetric Drug-Related Intertriginous and Flexural Exanthema.
    Mansilla Polo M; Martín-Torregrosa D
    N Engl J Med; 2024 Feb; 390(7):e17. PubMed ID: 38354144
    [No Abstract]   [Full Text] [Related]  

  • 69. Histopathological Spectrum and Immunophenotypic Characterization of Symmetrical Drug-Related Intertriginous and Flexural Exanthema.
    Muresan AM; Metze D; Böer-Auer A; Braun SA
    Am J Dermatopathol; 2021 Feb; 43(2):103-111. PubMed ID: 32618703
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pseudoephedrine-induced acute generalized exanthematous pustulosis.
    Ben Salem C; Slim R; Denguezli M; Sriha B; Hmouda H; Bouraoui K
    Int J Dermatol; 2008 Apr; 47(4):418-9. PubMed ID: 18377615
    [No Abstract]   [Full Text] [Related]  

  • 71. Pustulobullous variant of SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).
    Magnolo N; Metze D; Ständer S
    J Dtsch Dermatol Ges; 2017 Jun; 15(6):657-659. PubMed ID: 28514083
    [No Abstract]   [Full Text] [Related]  

  • 72. Symmetric drug-related intertriginous and flexural exanthema-like eruption related to coronavirus disease 2019 vaccine.
    Hong JK; Shin SH; Yoo KH; Li K; Seo SJ
    Contact Dermatitis; 2022 Jul; 87(1):91-93. PubMed ID: 35243643
    [No Abstract]   [Full Text] [Related]  

  • 73. An unusual unilateral 'rash' in the postoperative period.
    Ford A
    Anaesth Intensive Care; 2007 Feb; 35(1):146-7. PubMed ID: 17323690
    [No Abstract]   [Full Text] [Related]  

  • 74. Symmetrical drug-related intertriginous and flexural exanthema: a rare and unusual drug eruption.
    Lyons D; Barry R; Ni Raghallaigh S
    BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38199652
    [No Abstract]   [Full Text] [Related]  

  • 75. Symmetric drug-related intertriginous and flexural exanthema due to super-bioavailable itraconazole.
    Dhabal A; Das NK; Sil A
    Indian J Pharmacol; 2023; 55(3):192-193. PubMed ID: 37555417
    [No Abstract]   [Full Text] [Related]  

  • 76. Acetaminophen-induced exanthem of the breasts.
    Arora R; Maddox CL
    Cutis; 2012 Jun; 89(6):284-6. PubMed ID: 22838093
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cutaneous drug eruptions including serum sickness-like reaction, symmetrical drug-related intertriginous and flexural exanthema, and drug-induced lupus.
    McNamara K; Hughes OB; Strowd LC
    Clin Dermatol; 2020; 38(6):641-647. PubMed ID: 33341198
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acute generalized exanthematous pustulosis following oral nystatin therapy: a report of three cases.
    Küchler A; Hamm H; Weidenthaler-Barth B; Kämpgen E; Bröcker EB
    Br J Dermatol; 1997 Nov; 137(5):808-11. PubMed ID: 9415247
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acute generalized exanthematous pustulosis induced by pentoxifylline.
    Patrizi A; Tabanelli M; Antonucci A; Neri I
    Int J Dermatol; 2007 Dec; 46(12):1310-2. PubMed ID: 18173533
    [No Abstract]   [Full Text] [Related]  

  • 80. Is cetuximab-induced rash conclusion really a remnant of the skin erythema dose?
    Oskan F; Belka C; Manapov F
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):462-3. PubMed ID: 24074919
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.